Mels Hoogendoorn

5PUBLICATIONS
31CO-AUTHORS
Haematological tumoursDisease surveillanceEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2023
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.

Camille Kockerols, Peter J M Valk, Nicole M A Blijlevens

|Nov 12, 2022
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands.

Geneviève I C G Ector, Inge G P Geelen, Avinash G Dinmohamed

|Dec 14, 2021
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial.

Simone Oerlemans, Lindy Paulina Johanna Arts, Jacobien M Kieffer

|Aug 25, 2021
Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view.

Frederick W Thielen, Marie-José Kersten, Pim Kuizenga

|Oct 31, 2017
Relapse in stage I(E) diffuse large B-cell lymphoma.

Marcel Nijland, Karin Boslooper, Gustaaf van Imhoff

Pageof 1

Frequent Collaborators

2 joint publications

Eduardus Fm Posthuma

2 joint publications

Nicole M A Blijlevens

2 joint publications

Peter E Westerweel

2 joint publications

Avinash G Dinmohamed